Improving Therapy of Chronic Lymphocytic Leukemia (CLL) with Chimeric Antigen Receptor (CAR) T Cells

par Fraietta, Joseph A., Schwab, Robert D., Maus, Marcela V.
Publié dans Semin Oncol (2016)

2137 Percentage of viable tumor Versus radiation treatment effect in surgical specimens is not associated with outcomes in recurrent glioblastoma

par Schwab, Robert D., Bagley, Stephen, Binder, Zev, Lustig, Robert, O’Rourke, Donald, Brem, Steven, Desai, Arati S., Nasrallah, MacLean
Publié dans J Clin Transl Sci (2018)

Protamine loops DNA in multiple steps

par Ukogu, Obinna A, Smith, Adam D, Devenica, Luka M, Bediako, Hilary, McMillan, Ryan B, Ma, Yuxing, Balaji, Ashwin, Schwab, Robert D, Anwar, Shahzad, Dasgupta, Moumita, Carter, Ashley R
Publié dans Nucleic Acids Res (2020)

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma

par Posey, Avery D., Schwab, Robert D., Boesteanu, Alina C., Steentoft, Catharina, Mandel, Ulla, Engels, Boris, Stone, Jennifer D., Madsen, Thomas D., Schreiber, Karin, Haines, Kathleen M., Cogdill, Alexandria P., Chen, Taylor J., Song, Decheng, Scholler, John, Kranz, David M., Feldman, Michael D., Young, Regina, Keith, Brian, Schreiber, Hans, Clausen, Henrik, Johnson, Laura A., June, Carl H.
Publié dans Immunity (2016)